A Multi-center Phase II Clinical trial of 3rd and more line TS-1 treatment for Advanced NSCLC
Phase 2
- Conditions
- SCLC
- Registration Number
- JPRN-UMIN000004295
- Lead Sponsor
- Ehime University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with serious infections or susupected infections with fever 2)complication of massive pericardial effusion, ascites or pleural sffusion 3)uncontrollable heart failure or Interstitial pneumonitis 4)Pregnant or lactating woman 5)Symptomatic brain metastasis 6)Hystory of active double cancer 7)poorly controled diabetes mellitus 8)Patients whose participation in the trial is judged to be inappropriate by the attending doctor.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method